Business Context and Reporting Period
Company: Ginkgo Bioworks Holdings, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: February 26, 2026
Reporting Period: Fourth Quarter 2025 and Year Ended December 31, 2025
This filing serves as a notification that the company issued a press release on February 26, 2026, announcing its financial results for the specified periods. The detailed results are contained in Exhibit 99.1.
Key Financial Metrics
The provided Form 8-K text does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are referenced as being included in the press release (Exhibit 99.1) but are not detailed within the body of this filing.
Material Changes
No material changes or comparative financial data versus prior periods are disclosed in the text of this Form 8-K. The filing solely references the issuance of the results announcement.
Guidance, Outlook, and Risks
The filing text does not provide specific guidance, management commentary, risk factors, or details on contingencies and unusual items. Such information is expected to be found in the referenced press release (Exhibit 99.1).
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for actual Q4 2025 and full-year 2025 financial figures.
- Verify year-over-year revenue growth and net loss trends in the full press release.
- Check for updated forward-looking guidance or operational milestones announced in the press release.
- Confirm cash position and burn rate details not present in this summary filing.